Abstract: Guided bone regeneration (GBR) evolved from the concept of guided tissue regeneration (GTR) and has been used for reconstructing sites with bone deficiencies associated with dental implants. For GBR, the use of absorbable collagen membranes has been increasing, but, at present, scientific information on the use of collagen membranes for GBR is limited. This study was aimed to clinically and histomorphometrically compare two collagen membranes, Bio-Gide A and BioMend Extend TM , for the treatment of implant dehiscence defects in eight mongrel dogs. Implant dehiscence defects were surgically created in edentulous ridges, followed by the placement of three endosseous implants bilaterally in the mandible. Each implant dehiscence defect was randomly assigned to one of three treatment groups: (1) control (no membrane), (2) porcine dermis collagen barrier (Bio-Gide) or (3) bovine tendon collagen barrier (BioMend Extend). Dogs were sacrificed at 4 and 16 weeks (four dogs each) after treatment. Histomorphometric analysis included percentage linear bone fill (LF), new bone-to-implant contact (BIC) and area of new bone fill (BF). The results of the study revealed no significant differences among groups for any parameter at 4 weeks. However, at 16 weeks, more LF, BIC, and BF were noted in the membrane-treated groups than controls. BioMend Extend-treated defects demonstrated significantly greater BIC than control (P Ͻ 0.05) at this time point. BIC at 16 weeks was significantly greater than 4-week BIC (P Ͻ 0.05). Membrane exposure occurred in 9 out of 15 sites examined, resulting in significantly less LF and BIC than the sites without membrane exposure (P Ͻ 0.05). The results of this study indicate that: (1) GBR treatment with collagen membranes may significantly enhance bone regeneration, manifested at late stage (16 weeks) of healing; and (2) space maintenance and membrane coverage were the two most important factors affecting GBR using bioabsorbable collagen membranes.
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The demand for replacing missing teeth with dental implants has increased dramatically; however, it has often been limited by the amount of available bone. Guided bone regeneration (GBR) was introduced to correct this deficiency and has shown promising results. The concept of GBR evolved from guided tissue regeneration (GTR) and is used to compartmentalize neosteogenesis using barrier membranes by protecting the blood clot, creating space, and excluding soft tissue cell proliferation (Boyne 1969; Dahlin et al. 1988; Dahlin et al. 1991; Linde et al. 1993a) . Fugazzotto et al. (1997) assessed 1503 GBR-treated implant sites with clinical reentries and reported an overall success rate of 97.0% for the treatment of dehisced or fenestrated implants placed in immediate extraction sockets. Hermann & Buser (1996) discussed five surgical factors that are required to achieve predictable results with GBR procedures: 1 use of an appropriate membrane; 2 achievement of primary soft tissue healing; 3 creation and maintenance of a membrane-protected space; 4 close adaptation and stabilization of the membrane to the surrounding bone; 5 sufficiently long healing period.
While GTR procedures are associated with natural teeth, GBR is mainly involved in implant dentistry where inadequate bone is the concern. Adequate bone volume is one of the requirements for the successful installation and osseointegration of an endosseous implant (Lekholm & Zarb 1985) . GBR is often used in extraction sockets, deficient ridges, and dehiscence and fenestration defects, associated with dental implants (Mellonig & Nevins 1995) .
Prerequisites for an ideal barrier membrane include biocompatibility, cell occlusivity, tissue integration, space-making effect, and clinical manageability. The e-PTFE membrane, nonabsorbable, appears to fulfill these needs. However, it has been recognized that the use of the nonabsorbable membrane has been limited by the necessity of second surgery for membrane removal and its high membrane exposure rate (Gotfredsen et al. 1993; Becker et al. 1994; Simion et al. 1994a) , potentially resulting in patient discomfort, increased cost, postsurgical infection, and possibly suboptimal bone regeneration. Bioabsorbable membranes were then developed and have demonstrated comparable results to the e-PTFE membrane in numerous experimental animal studies (Sandberg et al. 1993; Sevor et al. 1993; Zellin et al. 1995) and case reports (Balshi et al. 1991; Sevor & Meffert 1992; Lundgren et al. 1994; Mayfield et al. 1997 ). Currently tested and used absorbable membranes are made of collagen or of polyglycolic acid, polylactic acid, or copolymers (Hutmacher et al. 1996; Wang & MacNeil 1998) .
Collagen membranes are mechanically malleable, adaptable, and easy to manipulate, which may be beneficial in clinical application. Other advantageous properties of collagen include hemostatic function, facil-itating early wound stabilization, semipermeability, allowing nutrient passage, natural enzymatic degradation, and chemotactic ability to attract fibroblasts (Postlethwaite et al. 1978) . The safety and efficacy of collagen membranes have been proven in the field of GTR (Blumenthal 1988; Wang et al. 1994; Crigger et al. 1996; Yukna & Yukna 1996) as well as in GBR (Sevor et al. 1993; Zitzmann et al. 1997; Hürzeler et al. 1998) . Hürzeler et al. (1998) Buccal dehiscence defects are one of the most commonly encountered problems in implant dentistry. There have been a number of experimental and clinical studies on GBR using this type of defect (Zablotsky et al. 1991; Becker et al. 1992; Sevor et al. 1993; Zitzmann et al. 1997; Hämmerle et al. 1998; Peleg et al. 1999) . Compared to the lingual bone, especially in the maxillary anterior region, buccal bony housing is thin; thus, bone resorption after tooth extraction in buccal areas is faster and far more prevalent. According to Lam (1960) , the abundant bone volume does not remain more than a few years following tooth loss, and the original crestal width is reduced by at least 30% within 2years after extraction. To overcome the difficulty of space creation around buccal dehiscence defects, several treatment approaches, such as membranes with space fillers or titanium-reinforced e-PTFE membranes, are often utilized in GBR (Simion et al. 1994b; Fritz et al. 2000) Longevity and space-maintaining ability are the most challenging concerns regarding absorbable membranes in GBR procedures. Studies have demonstrated that early removal of membranes resulted in reduced bone formation and incomplete bone fill (Lekholm et al. 1993; Becker et al. 1994) . Several clinicians have advocated that membranes used for GBR should last longer, ranging 3-9months, than GTR membranes. Bio-Gide, a collagen membrane claimed to last 4-6months, was developed to fulfill this goal. Several other companies have also developed other longlasting membranes, including BioMend Extend TM (Sulzer Calcitek, Carlsbad, CA, USA) and Ossix TM (Implant Innovations, Inc., Palm Beach Gardens, FL, USA).
Bio-Gide is derived from porcine dermis and composed of type I and III collagen. It has two layers: (1) the compact layer, designed to protect soft tissue invasion; and (2) the porous layer, designed to facilitate integration of newly formed bone. BioMend Extend is a type 1 collagen membrane derived from bovine tendon and is highly cross-linked to prolong membrane barrier function to maximize time necessary for tissue regeneration.
There have been limited histomorphometric studies specifically on GBR using collagen membranes. The present study was aimed to compare, clinically and histomorphometrically, the effects of two different collagen membranes (BioGide and BioMend Extend) on GBR in surgically created buccal implant dehiscence defects in dogs.
Material and methods
Eight systemically healthy male mongrel dogs, aged from 1 to 2years and weighing 24-43kg, were used in this study. The dogs had full, well-aligned dentitions without clinical signs of destructive periodontal disease. The study was performed following approval by the University Committee on Use and Care of Animals (UCUCA) at the University of Michigan.
Surgical management
After an adaptation period of 4weeks, each animal received full-mouth scaling and extraction of the mandibular 2nd, 3rd, and 4th premolars (P2-P4) bilaterally under general anesthesia. After 16weeks of healing, buccal dehiscence defects were prepared as described by Becker et al. (1992) . Midcrestal incisions followed by full thickness mucoperiosteal flap elevation were performed, and the crestal bone was uniformly prepared by osteoplasty using a round bur or bone chisel. Following implant site preparation (surgery protocol by Sulzer Calcitek), buccal dehiscence defects, approximately 4mm in height from the crestal bone, 3mm in depth from the surface of the buccal bone, and 3mm in width mesiodistally, were created with a straight fissure carbide bur. The osteotomy procedures were carried out under copious saline irrigation. The defect size was stan-dardized with the use of a periodontal probe. After defect creation, three titanium threaded implants (Spline   TM   TWIST  MTX   TM , Sulzer Calcitek, Carlsbad, CA, USA), 3.75mm in diameter and 8mm in length, were placed in each quadrant, and three treatment modalities (Bio-Gide, BioMend Extend or control) were randomly assigned to each implant defect using a random number table (Fig.1) . Block randomization was used for grouping with each quadrant as a block. The membranes were trimmed and placed over the defects to cover the implant and defect, extending 2-3mm beyond the defect margin. Primary wound closure was accomplished by flap releasing and closure with 4-0 Vicryl (polyglactin 910) suture using the simple interrupted suture technique to achieve primary intention healing.
Oral hygiene and diet
During the presurgical period, animals received three times weekly toothbrushing with a soft brush and 0.2% chlorhexidine gel. Following surgery, chlorhexidine swabbing of tissues was performed in lieu of brushing for 2weeks. The dogs were fed a daily canine diet (LabDiet Certified Canine Diet 5007, PMI Feeds, Inc., ) and filtered tap water ad libitum. For the first 3weeks after surgery, a soft diet was used to minimize mechanical trauma to the flaps.
Bone labeling
To assess the pattern of osteogenesis and delineate the base of the original defect, three fluorochrome bone labels were used. For the 4-week biopsy group, a series of three bone labels were administrated in the following sequence (Giannobile et al. 1998) :
after the surgery; O tetracycline HCl (10mg/kg, I.M.) 2days prior to sacrifice.
For 16-week biopsy specimens, animals received a series of four bone labels:
O calcein green (8mg/kg, IM) 2days after implant placement; O xylenol orange (60mg/kg, IV) 8weeks after surgery; O tetracycline HCl (10mg/kg, IM) 12 weeks after surgery; O alizarin red (25mg/kg, IM) 2days prior to sacrifice.
Therefore, these labels were administered to determine the rate and extent of osteogenesis at 2, 4, 8, 12, and 16 weeks postsurgery.
Clinical reentry and histological procedure
Animal sacrifice was carried out after 4weeks (nΩ4 dogs) and after 16weeks (nΩ 4 dogs) with an overdose of pentobarbital (65 mg/kg, IV, to effect). At animal sacrifice, clinical reentry was performed on one quadrant at each time point to accrue clinical information and supplement histology data. Block biopsies of each quadrant including three implants and surrounding tissues were obtained, fixed in 10% neutral buffered formalin for 4-7days and then stored in 70% ethanol solution individually. These specimens were then dehydrated using ascending grades of alcohol, infiltrated, and embedded in methyl methacrylate (MMA) for nondecalcified sectioning (Sanderson & Kitabayashi 1994) . The orientation of the sections was transverse along the length of the implant which presented a view of the buccal defects. Three serial sections, 500mm in thickness, were taken along the long axis of the implant at the central portion of the fixture using a diamond wire saw (Well Diamond Wire Saws, Inc., Norcross, GA, USA). Each section was glued to a plastic slide (Wasatch Histo Consultants, Inc., Winnemucca, NV, USA) (Bloebaum et al. 1989) , ground to approximately 50-70mm utilizing an EXAKT Micro Grinder 400 (Exakt Medical Instruments Inc., Oklahoma City, OK, USA), and polished to an optical finish. One section per each implant site was left unstained for fluorescence analysis, and the two remaining sections were stained with Sanderson's Rapid Bone Stain TM (Surgipath Medical Industries, Richmond, IL, USA) and an acid fuchsin counterstain. Histomorphometric analyses as well as microscopic observation were performed by a calibrated, blinded examiner. For histomorphometric measurements, microscopic images were trans- (Fig.2) .
Descriptive histologic findings were also noted, such as pattern of osteogenesis, cell distributions, membrane remnants, membrane collapse, and fiber content.
Statistical analysis
For the assessment of the various treatment outcomes, two-tailed Student t-test was used for the mean differences within each group between 4 and 16weeks, and pairwise one-way ANOVA was used for overall mean differences between groups at each time point. For the comparison in the treatment outcomes between membrane exposure and nonexposure groups, twotailed Student t-test was utilized. For all statistics, the significance level used was PϽ0.05, and the data were presented as mean∫standard error.
Results
The animals demonstrated clinical signs of healing within normal limits with no signs of infection or wound dehiscence. One implant in the 16-week group (BioMend Extend site) was lost during the healing period. Clinical reentry revealed no thread exposure in any reentered site, but the superficial layer of the defect fill resembled granulation tissue in appearance and texture. For histomorphometric analyses, the implant sites for clinical reentry were left intact, without removal of the granulation tissue. Membrane exposure was noted in nine out of 15 membrane-placed implant sites, five Bio-Gide and four BioMend Extend, at 16weeks (one failed implant site was excluded). The exposure, when present, generally occurred with both membrane sites of the quadrant in a similar pattern.
Histologic observation
Histologically, four implants (one Bio-Gide at 16weeks and three controls, one at 4weeks and two at 16weeks) failed to demonstrate osseointegration, revealing fibrous encapsulation of the fixture. Additionally, one implant site in 4-week BioMend Extend group did not provide discernible sections and was excluded for histological evaluation. Therefore, the histologic and histometric analyses were carried out on a total of 42 specimens, 21 specimens for each time period.
In all groups, 4-week specimens demonstrated woven bone formation, characterized by abundant trabecular pattern and bone marrow spaces, and the level of BIC was generally very low (Fig.3) . All membrane-treated sites demonstrated space maintenance underneath barrier membranes. Under higher magnification, the regenerated bone presented high levels of trabecular pattern, lined with osteoid seams and numerous osteoblast-like cells, and the bone trabeculae were in close contact with blood vessels, revealing active angiogenesis and osteogenesis in this early healing phase.
In contrast to the 4-week observation, more organized, dense, and mature bone was generally noted for the 16-week specimens, suggesting lamellar bone formation, and intimate contacts between the bone and implant were frequently observed (Fig.4 ). There were signs of membrane disintegration, with membrane remnants visible in all membrane sites. Higher magnification demonstrated the presence of numerous osteoblasts, especially outside the border of the defect and near implant threads, suggesting continuous deposition of lamellar bone into a previously outlined bone envelope. Membrane collapse was histologically revealed in nine sites, eight membrane-exposed sites (five Bio-Gide and three BioMend Extend sites) and one nonexposed site (Bio-Gide).
At 4weeks, newly formed bone was clearly demarcated with previously present lamellar bone by different levels of stain, while the junction between new and old bone was not clearly differentiable at 16weeks. Fluorochrome labeling (calcein green) was used to histologically ensure or identify the junction between the old and newly formed bone (Fig.5) . In addition, fluorescence findings revealed that the pattern of osteogenesis until 4weeks appeared as a volumetric increase of osseous tissues into defect areas, whereas there were signs of density increase in a previously occupied area in 16-week specimens.
Histomorphometric analysis
Calibration of intra-and interexaminer errors in histometric measurements resulted in 99.3% intraexaminer (TO) and 96.9% interexaminer agreement with the reference examiner (W.G.). Table1 lists histometric comparison between time (4 and 16weeks) and treatment groups. There were no statistically significant differences between groups in baseline defects, range 3.08-3.41mm, at either time point (4 and 16weeks). At 4weeks, no statistically significant differences were noted in any of the assessed parameters. The mean LF was in the range of 65-70%. The mean BIC ranged from 11% to 19% among groups, and BF ranged from 1.12mm 2 to 1.46mm 2 . At 16weeks, there was a trend for greater improvements in membrane groups when compared to the control group for all parameters. There was statistically significantly more new BIC found in BioMend Extend compared to the control at 
Discussion
Utilizing two different collagen membranes to enhance bone augmentation in implant dehiscence defects were clinically and histologically evaluated in this canine study. Histologic analysis can be con- 
. aªBio-Gide
A (nΩ8): The newly formed bone was not readily distinguishable from old bone at the junction (j). The membrane (arrow) was mixed with collagen-rich fibers (asterisk), beginning to disintegrate. bªBioMend Extend TM (nΩ7): A space had been maintained with a barrier membrane.
Evidence of new bone formation and new BIC can be noted. cªControl (nΩ6): There was little evidence of space maintenance in this control specimen. dªHigher magnification: Membrane remnants (arrow) and numerous osteoblasts were observed especially outside border of the defect. Note the intimate contact between the implant threads and newly formed bone. 1993b; Sandberg et al. 1993; Schenk et al. 1994; Zellin et al. 1995) .
The histomorphometric analysis in this study demonstrated that the placement of collagen membranes enhanced bone regeneration as determined at 16weeks of healing, including regeneration of bone height and volume as well as bone-to-implant contact. Becker et al. (1992) studied GBR in implant dehiscence defects in dogs. Clinical reentry data at 18 weeks of the study revealed that the e-PTFE membrane alone group gained approximately 90% of LF, higher than the average LF of the membrane groups in the present study. Histometric analysis at 18 weeks in the study by Becker et al. (1992) demonstrated that new BIC was 23% for the e-PTFE alone group and 41% for e-PTFE plus growth factors group; on the other hand, the new BIC of BioMend Extend group in this study was almost 45%. The differences between the two studies in LF and new BIC are likely attributed to several factors. In the Becker et al. (1992) study, the implant dehiscence defects were created around immediate extraction sockets that were longer (i.e. 5mm in height). In addition, the methods of evaluating the defect resolution were different: Becker et al. (1992) used clinical measurements at reentry to assess LF whereas histometric analysis was used in the current study. It can be speculated that there would be a difference between clinical and histometric measurements in assessing degree of healing after GBR. Schliephake et al. (2000) histometrically analyzed linear bone fill (LF), comparing a polylactic acid (PLA) absorbable membrane and e-PTFE membrane used for GBR around surgically created circumferential implant defects in dogs. The study reported that the average LF at 3months reached approximately 45% in e-PTFE group and 40% in PLA group, lower than the present study and considerably less than Becker et al. (1992) ƒs clinical data. Moreover, in the current study, clinical observation at re-entry showed no thread exposure, which was different from the histometric data showing approximately 60% of LF at 16weeks. However, due to the limited sites of clinical re-entry, it was not possible to statistically compare the two measures of analysis. Third, the different types of implant surfaces used in the two studies should be considered. Machined titanium implants were used in Becker et al. (1992) , while microtextured (grit-blasted) implants were placed in the present study. It has been demonstrated that the level of new BIC is significantly influenced by implant surface roughness, being greater BIC in surfaceroughened implants compared to machined titanium surfaces (Buser et al. 1991; Stentz et al. 1997; Buser et al. 1998; Wennerberg et al. 1998; Cochran 1999) . Other factors for the different outcomes between the two studies may include use of different types of membrane barriers.
Histometric comparison between 4 and 16weeks demonstrated that there was significant increase in BIC (PϽ0.05) at 16weeks. This finding may be explained by progressing contact osseointegration, associated with bone maturation. Interestingly, there were no significant differences between early and late healing in LF and BF, except for a significantly lower LF at 16weeks than 4weeks in control group . aªSite with membrane exposure (nΩ9): The soft tissue and membrane were collapsed, resulting in less bone regeneration. bªSite without membrane exposure (nΩ6): The structural integrity of the barrier membrane remained undisturbed, with space maintenance for new bone formation (PϽ0.05). This is mainly attributed to several inherent problems of the current study. The small sample size in association with biologic variability, manifested by considerably high standard deviation, might have influenced the lack of statisti- No exposure (n Ω 3) 3.10 ∫ 0.14 64.01 ∫ 7.32 57.10 ∫ 6.69* 2.01 ∫ 1.06 *Statistically significant difference between exposure and no exposure (P Ͻ 0.05).
Data were presented as mean ∫??num? standard error.
cal significance. In addition, membrane (or space) collapse and flap exposure might also have negatively influenced the outcome of the late stage of bone healing, resulting in less LF at 16weeks compared to at 4weeks. However, under the limit of the findings of this study, it is implied that as bone matures from early phase to late stage of healing, BIC and density increase, without significant increases in bone height or bone fill. There could be a question raised as to whether or not the pattern of bone maturation involves bone volume reduction accompanied by density increase. Significant differences in treatment outcomes between sites with membrane exposure and nonexposed sites may impose a great clinical relevance. The sites with no membrane exposure demonstrated significantly greater LF, BIC, and BF, supported by other experimental and clinical studies (Nowzari & Slots 1995; Gotfredsen et al. 1993; Lekholm et al. 1993; Becker et al. 1994; Gher et al. 1994; Simion et al. 1994a; Kohal et al. 1998; Parma-Benfenati et al. 1999) . Machtei (2001) recently performed a meta-analysis and reported that membrane exposure results in significantly less bone formation in GBR procedure, and when compared to GTR procedures, the negative effects on treatment outcomes were more detrimental, indicating that primary closure of healing wound in GBR procedures is a major factor for the success of new bone formation in dental implants. However, only two GBR studies were used for this analysis. Kohal et al. (1998) demonstrated that early membrane exposure resulted in significantly less BIC, expressed as torque required to remove implants, compared to nonexposed implant sites in a canine model. Possible reasons for the high membrane exposure rate in this study included a cage-chewing behavior of dogs (Henry et al. 1997 ) and remaining flap tension. Since the membrane exposure, when present, was observed in entire quadrant, including control site, the exposure would have been more likely induced by animal behavior (or remaining flap tension) rather than membrane materials.
Histologic observations at 16weeks demonstrated loss of membrane integrity even in the sites without membrane exposure, and a pattern of membrane collapse in most of the exposed sites (eight out of nine) in which less regeneration was obtained. This indicates that the treatment outcomes were mainly dependent upon the presence or absence of membrane exposure and/or space collapse, not significantly influenced by membrane resorption time. Owens & Yukna (2001) recently evaluated the pattern of collagen membrane resorption, comparing three different collagen membranes, Bio-Gide, AlloDerm A porcine-derived (LifeCell, Branchburg, NJ, USA), and AlloDerm A human-derived (LifeCell, Branchburg, NJ, USA), in dogs. They observed that all membranes had near-complete degradation by 3months and were completely absent by 4months. Crigger et al. (1996) reported that highly crosslinked collagen membranes resulted in significantly less attachment gain compared to weak cross-linked, rapid resorbing collagen membranes in periodontal defects in dogs. Several limitations were associated with the present study. This study is an animal study which provides a model to the human situation. Second, the small sample size in association with large biologic vari-ability might have affected the results of statistical significance. Third, GBR was employed in surgically created defects (acute wounds) rather than naturally occurring chronic lesions. The size of the defects used in the study might not be of and represent critical-size kinetic defects to measure the effects of GBR temporally. Finally, the negative influence of the high membrane exposure rate and space collapse noted in the present study could have been reduced by fixating membranes or adding space-maintaining materials, such as bone grafts or metal pins. Carpio et al. (2000) reported that membrane fixation at GBR surgery resulted in significantly less postoperative complications with greater bone regeneration, as compared to no membrane fixation. In addition, a histologic study in implant dehiscence defects in monkeys demonstrated that a combined use of barrier membranes and anorganic bovine bone substitutes (Bio-Oss) had greater gains in bone height and width at 6months, compared to other groups, including membrane alone, Bio-Oss alone, or control (Hämmerle et al. 1998) . The rationale for the use of bone substitutes in GBR may include: (1) space creation/maintenance, (2) acting as a scaffold for angiogenesis and perivascular cells such as osteoprogenitor cells, and (3) providing a carrier for bone growth factors (Hämmerle 1999) .
Under the limits of the present study, it was concluded that GBR treatment using collagen membranes, either Bio-Gide or BioMend Extend, may enhance bone regeneration, including bone height gain, new bone-to-implant contact, and bone fill, manifested at a later stage of healing. Space maintenance and prevention of membrane exposure during healing could be crucial factors for the success of GBR. 
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Resumen
La regeneració n ó sea guiada (GBR) evolucionó del concepto de regeneració n tisular guiada (GTR) y ha sido usada para reconstruir lugares con deficiencias ó seas asociadas con implantes dentales. Para la GBR, el uso de membranas reabsorbibles de colágeno se ha ido incrementando, pero en la actualidad, la informació n científica sobre el uso de las membranas de colágeno para GBR es limitada. Este estudio tuvo la intenció n de comparar clínica e histomorfometricamente dos membranas de colágeno, BioGide A y BioMendExtend TM , para el tratamiento de defectos de dehiscencia en implantes en 8 perros mongrel. Los defectos de dehiscencia se crearon quirú rgicamente en crestas edéntulas, seguida de la colocació n de 3 implantes endoó seos bilateralmente en la mandíbula. Cada defecto de dehiscencia fue asignado aleatoriamente a uno de los e grupos de tratamiento: (1) Control (sin membrana) (2) Barrera de colágeno de dermis porcina (Bio-Gide A ), o (3) Barrera de colágeno de tendó n bovino (BioMendExtend TM ). Los perros se sacrificaron a las 4 y 16 semanas (4 cada una) tras el tratamiento. El análisis histomorfomé-trico incluyó % lineal de relleno ó seo (LF), contacto nuevo hueso a implante (BIC) y área de relleno de nuevo hueso (BF). Los resultados del estudio no revelaron diferencias significativas entre los grupos para ningú n parámetro a las 4 semanas. Sin embargo, a las 16 semanas, se observó una mayor LF, BIC, y BF en los grupos tratados con membranas que en los controles. Los defectos tratados con BioMendExtend TM demostraron un mayor BIC que el control (pϽ0.05) en este punto. El BIC a las 16 semanas fue significativamente mayor que el BIC a las 4 semanas (pϽ0.05). La exposició n de la membrana ocurrió en 9 de los 15 lugares examinados, resultando en un menor LF y BIC que los lugares sin exposició n de la membrana (pϽ0.05). Los resultados de este estudio indican que: (1) El tratamiento de GBR con membranas de colágeno puede estimular significativamente la regeneració n ó sea, manifestada en estados tardios (16 semanas) de cicatrizació n; y (2) El mantenimiento del espacio y la cobertura de la membrana fueron los dos factores mas importantes que afectaron la GBR usando membranas de colágeno biorreabsorbibles.
